Nitazoxanide
55981-09-4
≥98%
307
Alinia; Daxon; [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate; Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-; N-(5-Nitro-2-thiazolyl)salicylamide acetate (ester); acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester; NTZ; [2-[
- Data sheet: View or download
- MSDS: View or download
Nitazoxanide is a nitrothiazole benzamide with anti-parasitic and anti-viral activity. It inhibits pyruvate-ferredoxin oxidoreductase in protozoa and anaerobic bacteria. It inhibits many anerobes in vitro, with MIC₉₀ values of 0.06 µg/ml-4 µg/ml. It inhibits different strains of influenza A virus replication with EC₅₀ values of 1, 0.5, and 1 µg/ml respectively. It is used to treat enteritis caused by Cryptosporidium parvum and Giardia lamblia in children and adults. It is in clinical trials for treatment against COVID-19.
-20°C
